Your browser doesn't support javascript.
loading
Deficiency of the Heterogeneous Nuclear Ribonucleoprotein U locus leads to delayed hindbrain neurogenesis.
Mastropasqua, Francesca; Oksanen, Marika; Soldini, Cristina; Alatar, Shemim; Arora, Abishek; Ballarino, Roberto; Molinari, Maya; Agostini, Federico; Poulet, Axel; Watts, Michelle; Rabkina, Ielyzaveta; Becker, Martin; Li, Danyang; Anderlid, Britt-Marie; Isaksson, Johan; Lundin Remnelius, Karl; Moslem, Mohsen; Jacob, Yannick; Falk, Anna; Crosetto, Nicola; Bienko, Magda; Santini, Emanuela; Borgkvist, Anders; Bölte, Sven; Tammimies, Kristiina.
Afiliação
  • Mastropasqua F; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.
  • Oksanen M; Astrid Lindgren Children's Hospital , Karolinska University Hospital, Region Stockholm, 17164 Stockholm, Sweden.
  • Soldini C; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.
  • Alatar S; Astrid Lindgren Children's Hospital , Karolinska University Hospital, Region Stockholm, 17164 Stockholm, Sweden.
  • Arora A; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.
  • Ballarino R; Astrid Lindgren Children's Hospital , Karolinska University Hospital, Region Stockholm, 17164 Stockholm, Sweden.
  • Molinari M; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.
  • Agostini F; Astrid Lindgren Children's Hospital , Karolinska University Hospital, Region Stockholm, 17164 Stockholm, Sweden.
  • Poulet A; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.
  • Watts M; Astrid Lindgren Children's Hospital , Karolinska University Hospital, Region Stockholm, 17164 Stockholm, Sweden.
  • Rabkina I; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Becker M; Science for Life Laboratory, Tomtebodavägen 23A, 17165 Solna, Sweden.
  • Li D; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17165 Stockholm, Sweden.
  • Anderlid BM; Department of Neuroscience, Karolinska Institutet, 17176 Solna, Sweden.
  • Isaksson J; Science for Life Laboratory, Tomtebodavägen 23A, 17165 Solna, Sweden.
  • Lundin Remnelius K; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17165 Stockholm, Sweden.
  • Moslem M; Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06511, USA.
  • Jacob Y; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.
  • Falk A; Astrid Lindgren Children's Hospital , Karolinska University Hospital, Region Stockholm, 17164 Stockholm, Sweden.
  • Crosetto N; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.
  • Bienko M; Astrid Lindgren Children's Hospital , Karolinska University Hospital, Region Stockholm, 17164 Stockholm, Sweden.
  • Santini E; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.
  • Borgkvist A; Astrid Lindgren Children's Hospital , Karolinska University Hospital, Region Stockholm, 17164 Stockholm, Sweden.
  • Bölte S; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women's and Children's Health, Karolinska Institute, Region Stockholm, 17164 Stockholm, Sweden.
  • Tammimies K; Astrid Lindgren Children's Hospital , Karolinska University Hospital, Region Stockholm, 17164 Stockholm, Sweden.
Biol Open ; 12(10)2023 10 15.
Article em En | MEDLINE | ID: mdl-37815090
ABSTRACT
Genetic variants affecting Heterogeneous Nuclear Ribonucleoprotein U (HNRNPU) have been identified in several neurodevelopmental disorders (NDDs). HNRNPU is widely expressed in the human brain and shows the highest postnatal expression in the cerebellum. Recent studies have investigated the role of HNRNPU in cerebral cortical development, but the effects of HNRNPU deficiency on cerebellar development remain unknown. Here, we describe the molecular and cellular outcomes of HNRNPU locus deficiency during in vitro neural differentiation of patient-derived and isogenic neuroepithelial stem cells with a hindbrain profile. We demonstrate that HNRNPU deficiency leads to chromatin remodeling of A/B compartments, and transcriptional rewiring, partly by impacting exon inclusion during mRNA processing. Genomic regions affected by the chromatin restructuring and host genes of exon usage differences show a strong enrichment for genes implicated in epilepsies, intellectual disability, and autism. Lastly, we show that at the cellular level HNRNPU downregulation leads to an increased fraction of neural progenitors in the maturing neuronal population. We conclude that the HNRNPU locus is involved in delayed commitment of neural progenitors to differentiate in cell types with hindbrain profile.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonucleoproteínas Nucleares Heterogêneas Grupo U / Transtornos do Neurodesenvolvimento Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Biol Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonucleoproteínas Nucleares Heterogêneas Grupo U / Transtornos do Neurodesenvolvimento Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Biol Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia